05/09/2024
3:06 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:06 PM | ADC Therapeutics (Subject)
MALLIK AMEET (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
5:51 AM | ADC Therapeutics (Filer)
| Form 424B5 | |
05/06/2024
5:38 AM | ADC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:29 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
8:31 PM | ADC Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SC 13G | |
04/26/2024
3:21 PM | ADC Therapeutics (Filer)
| Form DEFA14A | |
|
04/16/2024
3:16 PM | ADC Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024
3:06 PM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/15/2024
3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/13/2024
3:17 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024
3:14 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024
2:19 PM | ADC Therapeutics (Filer)
| Form ARS | |
03/13/2024
11:25 AM | ADC Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
6:39 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
8:15 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
8:47 AM | ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A | |
02/12/2024
9:13 AM | ADC Therapeutics (Subject)
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
| Form SC 13G/A | |
02/09/2024
8:50 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
8:45 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
7:00 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:30 PM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:15 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:00 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
7:00 PM | ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:01 PM | ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:02 PM | ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:04 PM | ADC Therapeutics (Issuer)
Hug Peter (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:05 PM | ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:06 PM | ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:07 PM | ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:08 PM | ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:09 PM | ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:10 PM | ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
6:56 PM | ADC Therapeutics (Issuer)
Rivers Tyrell (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
6:58 PM | ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
6:59 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Does this chart look familiar? (Ad) Investors who understand when to get in — and when to get out…
Can make a lot of money.
Like in the chart, I showed you above… Get all the information here. |
12/19/2023
6:00 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2023
3:25 PM | ADC Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2023
6:13 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023
6:16 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2023
6:01 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2023
6:07 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/20/2023
3:14 PM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2023
8:05 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023
3:16 PM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
